[Enfuvirtide desensitisation: due to a failed case].
A
A
López-de-Torre Querejazu
O
O
Ibarra Barrueta
A
A
Santos Ibañez
J
J
Mayo Suárez
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003888:Desensitization, Immunologic / Q000379:methods; D004342:Drug Hypersensitivity / Q000150:complications* / Q000628:therapy*; D004361:Drug Tolerance; D000077560:Enfuvirtide; D017809:Fatal Outcome; D015700:HIV Envelope Protein gp41 / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications / Q000601:surgery; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D010446:Peptide Fragments / Q000009:adverse effects / Q000627:therapeutic use*; D015819:Substance Abuse, Intravenous / Q000150:complications
D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D000077560:Enfuvirtide